IGF2BP3 and hepatocellular carcinoma: To further investigate the downstream mechanism of NC inhibiting HCC progression by targeting IGF2BP3, we conducted an intersection analysis of genes that can directly bind to IGF2BP3, genes with decreased mRNA and m6A levels after NC treatment, and genes with differentially high expression in HCC.